Sacramento, C.A. – Half of the supply of hydroxychloroquine has been cut off by India. This comes after President Trump has touted the medication and it’s potential use in the fight against COVID-19. India produces roughly 47% of the supply of the medication for the United States.
The move comes as many nations have taken stands against exports of items in order to protect themselves at home. India is the source not only for a large portion of the manufacturing of this medication, but also the chemicals needed to make it. As US manufacturers race to produce the medicine, they may face shortages of the compounds needed.
This comes after recent reports of how China is restricting exports of PPE from American companies back to the United States. President Trump also issued orders to US manufacturers to discontinue exports of certain equipment as well. But it does not stop the need of supplies in the US.
Dr Anthony Fauci has repeatedly warned that the medication may not be the cure that the US is seeking. However, he does not discount that it may work. Now the question comes if the medication will be available when needed. The United States has stockpiled some of the medication, but it may not be enough.
As the administration continues to move towards the follow phase as cases decline, this will be an important piece of the puzzle. Fauci has indicated that the virus may become seasonal. The United States will need a treatment or response if this is the case.
There are other potential treatments being researched as well. One vaccine, financed by Bill Gates, is starting human trials this week. There are many other potential treatment options in the works. The CDC has also announced the beginning of antibody testing. This will help determine just how far the disease spread has occurred.
You can contact JD through The Liberty Loft’s website or by Twitter. Please consider donating to support The Liberty Loft so we can continue to deliver the content you find here.